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Background: The aim of present study was to determine disease-related and psychological risk factors for sexual
dysfunction in women with multiple sclerosis (MS).
Methods: This was a clinical-based study conducted from September 2009 to June 2010 in Tehran, Iran. A
consecutive sample of female patients with MS was recruited from an outpatient clinic. The Female Sexual Function
Index (FSFI) was used to evaluate sexual function. In addition neurological impairment was measured using the
Kurtzke Expanded Disability Status Scale (EDSS), and depression was assessed using the Beck Depression Inventory-II
(BDI-II). Univariate and multiple logistic regression analyses were performed in order to examine the association
between sexual dysfunction and independent variables.
Results: In all, 226 women participated in the study. Of these, 125 women (55.3%) met the criteria for sexual
dysfunction. The mean age of participants was 35.7 years (SD = 8.07). The results obtained from multiple logistic
regression analysis indicated that the disease duration (OR for the disease duration of equal or greater than
9 years = 3.13, %95 CI = 1.29-7.57, P = 0.01), the disease course (OR for secondary progressive MS = 3.96, %95
CI = 1.55-10.10, P = 0.004) and the BDI score (OR = 1.11, %95 CI = 1.07-1.16, P < 0.001) were significant factors
contributing to sexual dysfunction in these patients.
Conclusions: The findings from this study indicated that the duration and severity of the disease in addition to
depression were the most significant factors that contributed to sexual dysfunction in women with multiple
sclerosis. The burden of disease and sexual dysfunction suggests the need for further attention to this patient
population.Background
Multiple sclerosis (MS) is a chronic neurological dis-
order that is characterized by disseminated demyelin-
ation of nerve fibers of the brain and spinal cord [1]. MS
affects both male and female gender, but the disease af-
fects women 2 to 3 times more than males [2]. Thus it is
not surprising that there are many women who are suf-
fering from the disease. MS severely destroys women’s
life in several aspects including disruption in sexual
functioning [3-5]. The prevalence of sexual dysfunction
in female patients with MS varies from 40 to 70% [6].* Correspondence: p_rahnama1381@yahoo.com; montazeri@acecr.ac.ir
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distribution, and reproduction in any mediumSeveral studies demonstrated that different risk fac-
tors contribute to the development of female sexual dys-
function in MS patients including presence of physical
disorders, neurological impairments, age at onset of the
disease, depression and anxiety [3,7-10].
The prevalence of MS in Iranian population is esti-
mated to be at least 51.9 per 100,000 [11]. Also, female-
to-male ratio for the disease is reported to be 3.11 [12].
Overall sexual dysfunction among Iranian females has
been reported in up to 31% of women [13], but to the best
knowledge of the authors prevalence of sexual dysfunction
in Iranian women with multiple sclerosis is unknown.
Sexuality is a sensitive issue in almost every culture in-
cluding Iran. Thus patients usually are reluctant to talk
about their sexual problems and often, sexual dys-
function goes under recognized and under treated. If fe-
male sexuality is disturbed then it might lead to severalentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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affects reproductive health and family planning. The aim
of present study was to determinant disease-related and
psychological risk factors for sexual dysfunction in women
with multiple sclerosis (MS) in order to recognize the
extent of the problem and perhaps provide appropriate
guidelines for planning managed care for these patients.
Methods
Design and procedure
This was a clinical-based study conducted in Tehran,
Iran, during a 9-months period from September 2009 to
June 2010. A consecutive sample of 226 female patients
with multiple sclerosis was recruited from the MS out-
patient clinic in a large teaching and referral hospital
affiliated to Tehran University of Medical Sciences. Cri-
teria for inclusion were: diagnosis of MS according to
the McDonald Revised criteria [15]; being married; ha-
ving Expanded Disability Status Scale (EDSS) score less
than or equal to 8 [16], and willingness to participate in
the study. Exclusion criteria were: pre-existing major
chronic illness, and not having sexual experience in life.
All patients had a full neurologic examination.
Questionnaires
We used several questionnaires to collect data:
1. A study specific questionnaire in order to collect
data on demographic, clinical, and obstetric
information.
2. The Female Sexual Function Index (FSFI) was used
to evaluate sexual function [17]. The FSFI is a
validated and widely used 19-items self-reported
measure of women’s sexual function including the
following dimensions: desire, arousal, lubrication,
orgasm, satisfaction, and pain. The psychometric
properties of the Iranian version of Female Sexual
Function Index are well documented [18].
Fortunately the authors performed sensitivity
analysis for the Iranian version and the cut-off point
for the scale was found to be 28 (sensitivity = 83%
and specificity = 82%). In addition the same study
carried out the Receiver Operating Characteristics
analysis (ROC) and reported that the Area under the
Curve (AUC) was 0.917. The study used the clinical
diagnostic as the gold standard and reported that 28
was the best cut-off value for predicting sexual
dysfunction. Thus, for the analysis purpose women
who scored equal or less than 28 on the FSFI were
identified as those who were suffering from sexual
dysfunction. Similarly the cut-off points for the
subscales also were indicated and reported as
follows: Desire = 3.3, Arousal = 3.4, Lubrication = 3.7,
Pain = 3.8, Orgasm = 3.4, Satisfaction = 3.8.3. Depression was assessed using the Beck Depression
Inventory-II (BDI-II) [19]. It is a widely used 21-
items self-reported measure that assesses the
presence and intensity of depressive symptoms
reflecting the similar symptoms suggested by the
Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) [20]. The Persian version of
inventory already has been validated in Iran [21].
4. The neurological impairment was assessed using the
Expanded Disability Status Scale (EDSS). The EDSS is
a gold standard for assessment of disability in people
with MS. A neurologist scored the EDSS for each
patient [16]. The score on the EDSS ranges from 1 to
9.5 where scores from 1.0 to 4.5 specify that patients
are fully capable of walking while higher scores
indicate that patients are severely impaired.
Analysis
Descriptive analysis was carried out to explore the data.
Participants were classified as with and without sexual
dysfunction based on the FSFI cut-off score as men-
tioned earlier. We used both univariate and multiple
logistic regression analyses to examine the association
between dependent (sexual dysfunction) and independent
variables. The level of significance was set at 5%. The SPSS
version 16 was used to analyze the data.
Ethics
The ethics committee of Shahed University approved the
study. We obtained written informed consent from par-
ticipants after comprehensive explanation of procedure
involved.
Results
Demographic and clinical characteristics of the study
sample
In all, 320 patients were approached and 226 partici-
pants have agreed to participate in the study, giving a re-
sponse rate of 71%. Overall, 125 women (55.3%) met the
criteria for sexual dysfunction. The mean age of partici-
pants was 35.7 years (SD = 8.07). The mean disease du-
ration of participants was 1.8 (SD = 0.79) years, and had
the following diagnosis: 169 patients (74.8%) had relaps-
ing remitting MS (RRMS), 4 women (1.8%) had primary
progressive MS (PPMS) and 53 patients (23.5%) had
secondary progressive MS (SPMS). Frequency of sexual
dysfunction was 49% in RRMS, 75% in SPMS and 50%
in PPMS. The detailed results are shown in Table 1.
Risk factors for sexual dysfunction
The association of sexual dysfunction and independent
variables was first examined by univariate logistic re-
gression analysis. The results showed that there were
significant associations between sexual dysfunction and
Table 1 Characteristics of the study sample and odds ratio for sexual dysfunction (n = 226)
With SD (n = 125) Without SD (n =101) OR (95% CI)*
No. (%) No. (%) P
Age (years)
≤ 35 54 (43.2) 63 (62.4) 1.0 (ref.)
> 35 71 (56.8) 38 (37.6) 2.18 (1.27–3.72) 0.004
Education
Higher 28 (22.4) 41 (40.5) 1.0 (ref.)
Primary/Secondary 97 (77.6) 60 (59.5) 2.36 (1.32–4.22) 0.003
Employment status
Employed 13 (10.4) 24 (23.8) 1.0 (ref.)
House wife 112 (89.6) 77 (76.2) 2.68 (1.28–5.59) 0.008
Duration of marriage (years)
>10 45 (36.0) 51 (50.5) 1.0 (ref.)
10–20 45 (36.0) 36 (35.6) 1.41 (0.78–2.56) 0.250
21–40 35 (28.0) 14 (13.9) 2.83 (1.35–5.92) 0.006
Disease duration (years)
0-8 82 (65.6) 87 (86.1) 1.0 (ref.)
≥ 9 43 (34.4) 14 (13.9) 3.25 (1.66–6.39) 0.001
Disease course
RRMS 83 (66.4) 86 (85.1) 1.0 (ref.)
PPMS 2 (1.61) 2 (2.0) 1.03 (0.14–7.52) 0.972
SPMS 40 (32.0) 13 (12.9) 3.18 (1.59–6.83) 0.001
EDSS score
0–4.5 82 (65.6) 83 (82.2) 1.0 (ref.)
5–8 43 (34.4) 18 (17.8) 2.41 (1.28–4.53) 0.006
BDI score (mean/SD) 22.20 (10.94) 12.48 (8.79) 1.11 (1.07–1.15) < 0.0001
* Derived from univariate logistic regression analyses while sexual dysfunction was considered as dependent variable and other characteristics were considered as
independent variable.
Table 2 The results obtained from multiple logistic
regression analysis indicating risk factors for sexual
dysfunction (n = 226)
Adjusted OR (95% CI) P
Disease duration (years)
0-8 1.0 (ref.)
≥ 9 3.13 (1.29–7.57) 0.01
Disease course
RRMS 1.0 (ref.)
PPMS 1.21 (0.15–9.69) 0.85
SPMS 3.96 (1.55–10.10) 0.004
BDI score 1.11 (1.07–1.16) < 0.001
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education (OR = 2.42, %95 CI = 1.34-4.37), employment
status (OR for housewife = 2.68, %95 CI = 1.28-5.59), dur-
ation of marriage (OR for 21–40 years = 2.83, %95 CI =
1.35-5.92), the disease duration (OR for ≥9 years = 3.25,
%95 CI = 1.66-6.39), the disease course (OR for SPMS =
3.18, %95 CI = 1.59-6.83), EDSS (OR for 5–8 = 2.41, %95
CI = 1.28-4.53), and the BDI (OR = 1.11, %95 CI = 1.07-
1.15). The results are shown in Table 1.
All significant findings in univariate analysis then were
entered into a multiple logistic regression model. As shown
in Table 2 the results indicated that the disease duration
(OR for ≥9 years 3.13, %95 CI = 1.29-7.57, P = 0.01), the
disease course (OR for secondary progressive MS = 3.96,
%95 CI = 1.55-10.10, P = 0.004) and the BDI score (OR =
1.11, %95 CI = 1.07-1.16, P < 0.001) were significant con-
tributing factors to sexual dysfunction in these patients.
Further analyses of the data for the subscales of ques-
tionnaire (desire, arousal, lubrication, orgasm, satisfac-
tion, and pain) are shown in Tables 3 and 4.Discussion
The findings from this study indicated that considering
the cut-off point of 28 on the FSFI, the prevalence of
sexual dysfunction among Iranian female with MS was
high (55.3%). However, one might argue that most studies
Table 3 Descriptive statistics for sexual dysfunctions for
subscales of the FSFI (n = 226)
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Table 4 The results obtained from the logistic regression







≤ 35 1.0 (ref.)
> 35 2.06 (1.14–3.69) 0.015
Arousal
Age
≤ 35 1.0 (ref.)
> 35 3.18 (1.80–5.62) < 0.001
Lubrication
Age
≤ 35 1.0 (ref.)
> 35 2.82 (1.34–5.92) 0.006
Pain
Age
≤ 35 1.0 (ref.)
> 35 4.58 (1.77–11.80) 0.002
Duration of marriage (years)
>10 1.0 (ref.)
10-20 2.84 (0.78–2.56) 0.042
21-40 2.92 (1.35–5.92) 0.113
Orgasm
Age
≤ 35 1.0 (ref.)
> 35 2.55 (1.41–4.61) 0.002
Disease duration (years)
0-8 1.0 (ref.)
≥ 9 0.42 (0.19–0.93) 0.033
BDI score 1.03 (1.00–1.06) 0.023
Satisfaction
Age
≤ 35 1.0 (ref.)
> 35 3.44 (1.70–6.96) 0.001
EDSS score
0-4.5 1.0 (ref.)
5-8 0.33 (0.11–0.95) 0.04
BDI score 1.04 (1.00–1.07) 0.012
* Derived from multiple logistic regression analysis while dysfunctions on the
above subscales were treated as dependent variables and age, education,
occupation, disease duration, marriage duration, disease severity, the EDSS
and the BDI scores were considered as independent variables. Only the
significant results are reported for each subscale.
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ing women with and without sexual dysfunction [22].
Then, our findings would have been decrease slightly. The
findings also showed that there was no significant as-
sociation between sexual dysfunction and age. In fact, al-
though age was significant factor in univariate analysis
(see Table 1), its effect was diminished when performing
multiple logistic regression analysis. This observation
might be explained by the fact that our sample consisted
of women who perhaps were less sexually active. Another
reason for such observation might be related to the small
sample size of the study. Studying 73 MS patients a similar
finding was reported by Khan et al. where they have found
no association between age and sexual dysfunction as
measured by the Sexual Frequency Scale [23].
The results of this study showed that duration of the
disease was associated with sexual dysfunction. This im-
plies that the more time passes, increased sexual dys-
function will occur. A study showed that the extent and
the number of sexual dysfunction symptoms increased
significantly in MS patients during 2-years follow-up
[24]. Similarly another study revealed that duration of
Mohammadi et al. BMC Neurology 2013, 13:83 Page 5 of 6
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function was longer than the duration in MS patients
without SD [25]. This might be explained by several rea-
sons including the fact that MS could have a negative
impact on relationship between patients and their sexual
partners [26], and that the high levels of stress among
patients’ partners might affect their emotional and sex-
ual functioning [27].
The results of this study confirmed the previous re-
ports where it has been shown that SD was associated
with progressive forms of MS [26,28]. It seems that there
is a very straightforward relationship between sexual
dysfunction in women with MS and progressive course
of the disease.
This study also showed that depression was associated
with sexual dysfunction in this population. Depression
in MS is a multidimensional problem that varies by dis-
ease related impairments, activity restrictions and unpre-
dictable prognosis [29,30]. Also, in patients with MS it is
significantly higher than healthy individuals [31,32] and
is considered as a common co-morbidity among patients
with multiple sclerosis [33,34]. Consistent with our find-
ings, other studies have reported that there was signifi-
cant correlation between presence of sexual dysfunction
and depression [9,28,35]. It has been suggested that de-
pression may be a prominent variable contributing to
the sexual difficulties in MS patients. In fact depressed
women might suffer from several symptoms including
affective and somatic symptoms. These symptoms all
contribute to female sexual dysfunction since they might
cause mood and desire disorders [36,37]. In addition,
women with depression might use medication and the
relationship between antidepressant medications and
sexual dysfunction are well documented [38]. Studies
have shown that sexual dysfunction commonly occurs
during antidepressant treatment and considered as com-
mon adverse effect of antidepressant treatment [39].Limitations
This study had some limitations. It was a cross-sectional
study. Also we obtained our sample from an outpatient
clinic. Thus, the results from this study must be inter-
preted with caution.Conclusion
The findings indicated that sexual dysfunction was fre-
quent in women with multiple sclerosis. The findings
also indicated that clinical and psychological factors
were the most important contributing variables to sexual
dysfunction in women with multiple sclerosis. The bur-
den of sexual dysfunction in addition to the disease bur-
den suggests the need for extra attention to this patient
population.Competing interests
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